FDA Grants Priority Review to Pafolacianine Sodium Injection in Ovarian Cancer
March 3, 2021 4:00 pmThe FDA has granted priority review to the new drug application for the novel compound pafolacianine sodium injection for use in the identification of ovarian cancer during surgery.
By Courtney Marabella
The FDA has granted priority review to the new